Today nearly 60 million Americans suffer from allergies — or roughly 20% of the population — yet less than 3% of allergic individuals are currently undergoing immunotherapy (the only treatment that changes your underlying allergic disease instead of temporarily treating symptoms).
Injection immunotherapy is an effective treatment, yet many allergy sufferers are not willing or able to consider this treatment. Sublingual immunotherapy, or allergy drops, is an off-label use of the same antigens used in allergy shots. Due to the better safety profile of allergy drops, more allergic individuals may be able to benefit from a treatment approach that addresses the cause of the allergies.
There are many benefits to consider with allergy drop treatment including reduced time spent for physician visits, the convenience of taking immunotherapy at home or on the go, the potential to treat a broad array of allergic patients and conditions, and the reduced need for allergy medications. Learn more about the steps to allergy drop treatment and how allergy sufferers could benefit.